• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Live Oak Bancshares Inc. (Amendment)

    2/14/24 11:25:50 AM ET
    $LOB
    Major Banks
    Finance
    Get the next $LOB alert in real time by email
    SC 13G/A 1 d780621dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Amendment #1

    Under the Securities and Exchange Act of 1934

     

     

    Live Oak Bancshares Inc

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    53803X105

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    This Schedule is filed pursuant to Rule 13d-1(b)

    The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

     

     

     


    CUSIP NO. 53803X105

     

     1)   

     Name of Reporting Person

     Ameriprise Financial, Inc.

     

     S.S. or I.R.S. Identification No. of Above Person

     IRS No. 13-3180631

     2)  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☒*

     

    *  This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

     3)  

     SEC Use Only

     

     4)  

     Citizenship or Place of Organization

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5)   

     Sole Voting Power

     

     0

       6)  

     Shared Voting Power

     

     810,043

       7)  

     Sole Dispositive Power

     

     0

       8)  

     Shared Dispositive Power

     

     884,296

     9)   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     884,296

    10)  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11)  

     Percent of Class Represented by Amount In Row (9)

     

     1.99%

    12)  

     Type of Reporting Person

     

     HC


    1(a)    Name of Issuer:    Live Oak Bancshares Inc
    1(b)    Address of Issuer’s Principal    1741 Tiburon Drive
       Executive Offices:    Wilmington, North Carolina 28403
    2(a)    Name of Person Filing:    Ameriprise Financial, Inc. (“AFI”)
    2(b)    Address of Principal Business Office:    Ameriprise Financial, Inc.
          145 Ameriprise Financial Center
          Minneapolis, MN 55474
    2(c)    Citizenship:    Delaware
    2(d)    Title of Class of Securities:    Common Stock
    2(e)    Cusip Number:    53803X105
    3    Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):
      

    Ameriprise Financial, Inc.

       A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)
    4    Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.
       AFI disclaims beneficial ownership of any shares reported on this Schedule.
    5    Ownership of 5% or Less of a Class:
       If this statement is being filed to report the fact as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following (X).
    6    Ownership of more than 5% on Behalf of Another Person: Not Applicable
    7    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: Not Applicable
    8    Identification and Classification of Members of the Group: Not Applicable
    9    Notice of Dissolution of Group: Not Applicable


    10    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 14, 2024

     

    Ameriprise Financial, Inc.
    By:  

    /s/ Michael G. Clarke

    Name:   Michael G. Clarke
    Title:   Senior Vice President, North America Head of Operations & Investor Services
    Contact Information
    Dominic Geddes
    Global Head of Reporting
    Global Operations and Investor Services
    Telephone: +442074645779
    Get the next $LOB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LOB

    DatePrice TargetRatingAnalyst
    10/5/2023$40.00Neutral → Overweight
    JP Morgan
    4/28/2023$25.00 → $26.50Underweight → Neutral
    JP Morgan
    2/27/2023Mkt Perform
    Raymond James
    12/13/2022$34.00 → $30.00Neutral → Underweight
    JP Morgan
    7/7/2022Outperform → Mkt Perform
    Raymond James
    7/1/2022$58.00 → $41.00Overweight → Neutral
    JP Morgan
    2/17/2022$75.00 → $85.00Overweight
    JP Morgan
    1/27/2022$100.00 → $80.00Outperform
    Raymond James
    More analyst ratings